That is essential, due to the fact that the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (tech stock). And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was an advancement practically nobody saw. But it's going to have extensive implications for treating illness. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of financial investment chances in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (democratic republic). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it drew back maybe substantially prior to going greater - legacy report prediction. I've been covering bitcoin for a long time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. However that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown 2021 stock predictions. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic personal business on the edge of hitting the general public markets And I've been working on a brand-new way for you to invest even before these business go public.
This chance has actually been constructing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to schedule your area free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers know that tech isn't our usual beat (tech predictions). And when it concerns tech investing, we leave it to the professionals. The good news is, we have several such professionals in our Rolodex. Our coworker Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we know (artificial intelligence). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and predict what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These patterns are experiencing exponential growth and developing unbelievable chances for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. brownstone research stock. However despite what many readers might believe, this is a pattern that's just starting. Although the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions 2021). Losing two months of manufacturing and sales truly impacts how numerous 5G devices are offered in the fiscal year. When you consider all of that, offering 250 million units is exceptional. More importantly, the delays brought on by the pandemic created a lots of suppressed need. Which demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be delivered in 2021 - social media. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its three different phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage 3, 5G services begin to be provided (jeff brown top stock pick 2021). That's when we begin to see applications running on 5G networks. Think of things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Stage Three by this summertime. This starts something of a virtuous cycle: The majority of people don't truly appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being developed. In fact, 5G is going to open up a suite of extraordinary applications: self-driving cars, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment chances moving forward will be enormous. Stepping away from 5G, the next crucial innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR uses a similar idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can remedy these "typos." For several years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And throughout that time, there were actually just 3 companies running in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and providing amazing returns. This entire industry is efficiently a greenfield chance.
There's room for lots of business to exist in this space. artificial intelligence. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary editing business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can precisely predict the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is very important due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental process. And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced utilizing this innovation. This was among those breakthroughs that nearly no one noticed. However it's going to have extensive ramifications for curing illness. And, naturally, there will be plenty of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe considerably before going higher. I've been covering bitcoin for a long time now. One of the first research study reports I ever released was on bitcoin - biotech stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. However at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche business. last week. Mass, Mutual is a 150-year-old organization. So think about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the details is up to date since February 2021, however we could not independently validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best known for his sage-like ability to pick winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience provides him an outstanding point of view on the market. He's constantly on the hunt for brand-new chances, and he shares many of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully predicted a few of the greatest financial occasions of the previous twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best every time, but Jeff Brown's precise forecasts have earned him legions of devoted fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research, a popular financial research publisher. Brownstone Research offers numerous research study services with a wide variety of expertises - tech stocks.
The company is also connected with Bonner & Partners, another well-respected research publisher - tech stock. On its site, Brownstone says its mission is to provide retail investors with professional-grade research: "For too long, the finest investment research has actually not been offered to specific financiers. It has been usually scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. longtime readers. The objective of Brownstone Research study is to make that sort of exclusive research readily available to any investors seeking to acquire an edge in the markets. The objective is basic to provide unique and lucrative financial investment research discovered nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he likewise works as the firm's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown biotech picks. Everything he touches relies on gold! Jeff is well conscious of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In truth, Brown believes S.A.V. tech stock. could be "the greatest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge technologies: synthetic intelligence and electrical automobiles. Musk hopes the combination will help him establish the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing brief of the automobile industry's Holy Grail. As you know, electric automobiles and self-driving vehicle stocks have actually been huge this year, however the Wall Street machine has approved buzz without much tangible outcome. In spite of an extreme boost in competitors over the previous couple of years, Brown still believes Musk has the very best opportunity of putting it all together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transport. Essentially, this innovation would permit you to rent your vehicle as an autonomous, self-driving taxi when you're not utilizing it. You merely leave the cars and truck and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a large portion of the earnings. It sounds outrageous, however it could be closed than you believe.